Close
What would you like to look for?
Site search
Search filters

NEMIS Technologies AG closed a CHF 7.75m Series A Financing Round

10 February 2022

NEMIS Technologies AG closed a CHF 7.75m Series A financing round with the participation of both institutional and private investors.

TargImmune financing round with CHF 17.7m.

16 July 2021

TargImmune Therapeutics has closed its 2021 financing round, raising CHF 17.7m.

Haya Therapeutics completes CHF 18m Seed Financing Round

21 May 2021

HAYA Therapeutics SA announced the successful closing of its CHF 18m seed round.

Spaeter Pension Fund sells residential real estate portfolio to 1291 AST

30 December 2020

The Spaeter Group's Pension Fund Foundation sells an attractive, highly profitable residential real estate portfolio with properties in four cantons of German-speaking Switzerland and with a total value of CHF 45.8m to 1291 Die Schweizer Anlagestiftung (AST) by means of a contribution in kind and transfer of assets in accordance with the Merger Act.

Azafaros expands executive management team and operations

14 July 2020

Azafaros B.V., headquartered in Leiden, The Netherlands, has recently incorporated a Swiss subsidiary in the pharma hub of Basel to strengthen its research and development operations. In addition, three experienced industry...

Transfer of CHF 500M real estate portfolio for Helvetia Insurance

5 June 2020

On 3rd of June 2020, Helvetia Asset Management AG has issued the real estate fund "Helvetia (CH) Swiss Property Fund". The fund has acquired a real estate portfolio with 29 properties and a total value of around CHF 532 million...

Dubai's DP World and Swissterminal enter strategic partnership

27 January 2020

DP World and Swissterminal, the leading container terminal operator in Switzerland, have entered a strategic partnership. DP World will take a stake of 44% in Swissterminal Holding AG with the Mayer family, the business' founder,...

Numab and Sunshine Guojian form partnership

20 December 2019

3SBio Inc.’s subsidiary Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (“Sunshine Guojian”) and Numab have formed a partnership focusing on the development and commercialization of a portfolio of novel multi-specific...

T3 Pharmaceuticals AG closes its second financing round

15 October 2019
2 October 2019

T3 Pharmaceuticals AG, a Basel-based company focusing on immuno-oncology, closes its second financing round of over 12M CHF with existing investors joined by Boehringer Ingelheim Venture Fund (BIVF) and Reference Capital SA.

VISC...

Versantis Closes CHF 16m Series B Financing Round

3 October 2019
2 October 2019

Versantis, a clinical-stage biotech company developing disruptive therapies for rare liver and pediatric diseases, completed an oversubscribed CHF 16 million Series B financing round. Swisscanto Invest by Zürcher Kantonalbank led...